JINSIY YO‘L BILAN YUQADIGAN INFEKSIYALARNI DAVOLASHDA NITROFURANLARNI QO‘LLASH

Maqolaning asosiy mazmuni

F.B. Mirodilova
N.S. Saipova
F.Kh. Abbaskhanova

Abstrak

Bakterial vaginoz nafaqat noxush ajralmalarning sababi, balki xavf omili, hatto ayollar jinsiy a’zolarining og‘ir patologiyasi hamda homiladorlik va tug‘ruq asoratlarining sababi hamdir. Qo‘llanilishi qin mikrobiotasining sezilarli yaxshilanishiga va bakterial vaginoz klinikasida ijobiy o‘zgarishlarga yordam beradi.

Maqola tafsilotlari

Bo'lim

Maqolalar

Qanday iqtibos keltirish kerak

JINSIY YO‘L BILAN YUQADIGAN INFEKSIYALARNI DAVOLASHDA NITROFURANLARNI QO‘LLASH. (2023). Research Focus International Scientific Journal, 2(1), 341-345. https://doi.org/10.66073/researchfocus.v2i1.2876

Adabiyotlar

Мартышкина Е.Ю. Неконтрацептивные эффекты гормональной контрацепции. Взгляд российских и зарубежных экспертов. Акушерство, гине-кология и репродук-ция. 2011; 3: 52-54.

Mendling W. Vulvovaginalmykosen. Klinikum Frankfurt (Oder), AkademischesLehrkrankenhaus der Humboldt–Universitat (Charite) zu Berlin. Z ArztlFortbildQualitatssich 1998; 92 (3): 175–9.

Rathod S.D., Klausner J.D., Krupp K., Reingold AL, Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology; 2012. Article ID 859071, 8 p.

Rylander E., Berglund A.-L., Krassny C., Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. SexuallyTransmittedInfections. 2004;80:54–57.

Dubini, E., Furnely, P., Antimicrobial activity of nitrofuran. Journal "Italian Chemotherapy", 32, 545., 1985.

Korshunov V.M., Volodin N.N., Efimov B.A. and other Microecology of the vagina. Correction of microflora in vaginal dysbacteriosis. // Textbook. - M., VUNMTs of the Ministry of Health of the Russian Federation, 1999. - 80s.

Mendling, W., Mayland, E., Microbiological and pharmaco-toxicological profile of nitrofuran and its favorable risk/benefit ratio in the treatment of vulvovaginal infections. Drug research. 52, 8 2002.

OAGC (Society of Obstetrics and Gynecology of Canada), Guidelines for Clinical Practice, Committee Recommendation No. 17, March 1997.

Balmer J.A., 1995; Serov V.N., Shapovalenko S.A., 2004.

Urogenital candidiasis. clinical recommendations. RODViK, ROAG, Utl. Ministry of Health of the Russian Federation 2016. M., 2016. 22p. (in Russian).